BEDSIDE NGAL IN PCI - Early detection of renal damage by bedside NGAL assessment in patients undergoing PCI
Project objectivesTo assess the sensitivity and specificity of bedside neutrophil gelatinase-associated lipocalin (NGAL) measurement in the diagnosis of contrast-induced nephropathy in patients undergoing coronary stenting. To study the long-term prognostic role of this molecule by correlating pre- and post-procedural values with cardiovascular outcomes. |
Start and end date |
|
January 2013 - ongoing |
Project Manager |
|
Dr. Annunziata Nusca - Principal Investigator Prof. Germano Di Sciascio |
Coordinating institution of the project |
|
Università Campus Bio-Medico di Roma |
